Watch Ticker

Alector, Inc. Common Stock

Go to Alector, Inc. Common Stock Website

$1.56

0.00 (0.00%)

Live

Previous Close

$1.56

Day Range

$0 - $0

Previous Day Range

$1.51 - $1.595

Market Cap

$155.0 million USD

Day Vol.

Previous Day Vol.

603534

Currency

USD

Primary Exchange

Nasdaq

Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pa...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Alector to Participate in Upcoming Healthcare Conferences

Alector, a late-stage clinical biotechnology company, announced that it will participate in upcoming investor conferences, where it will present its therapies for neurodegenerative diseases.

Related tickers: ALEC.

Read Full Article

N/A - Alector Reports on Recent Progress and Outlines Strategic Priorities for 2025

Alector, a late-stage clinical biotechnology company, provided an update on its pipeline, including the anticipated topline data from the pivotal INFRONT-3 Phase 3 trial of latozinemab in frontotemporal dementia with a granulin gene mutation, and the ongoing PROGRESS-AD Phase 2 trial of AL101/GSK4527226 for early Alzheimer's disease. The company also highlighted its preclinical and research pipeline, including programs leveraging its Alector Brain Carrier technology.

Related tickers: ALEC, GSK.

Read Full Article

Trending Tickers

Please sign in to view